Topic search: ADVERSE DRUG EVENTS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Adverse Drug Events Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2025 Pg. 33-36	Compounded GLP-1 Drugs and Patient Adverse Events Author(s): Alliance for Pharmacy Compounding
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Jan/Feb 2024 Pg. 16-21	The Physiologic Role and Use of Estriol Author(s): Paoletti Jim E
Nov/Dec 2023 Pg. 450-453	Drug Utilization Review: Our Patients Deserve Our Very Best Author(s): Jackson Kathleen
Nov/Dec 2023 Pg. 483-486	Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 358-360	Major Study Affirming the Relative Safety of Testosterone-replacement Therapy Author(s): Biundo Bruce
Sep/Oct 2023 Pg. 362-366	Compounding Metformin for Use in Functional Medicine Author(s): Desai Sarina, Thompson Tara
Sep/Oct 2023 Pg. 368-380	Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment Author(s): Riepl Mike, Kaiser Joe
Sep/Oct 2023 Pg. 382-385	Excipients and Adverse Events Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 278-283	Topical Vehicles: A Dermatologist's Perspective Author(s): Adame Stephanie, Collins Michael E, Korman Abraham M
Jan/Feb 2023 Pg. 30-37	Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 436-439	Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Author(s): Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Jul/Aug 2022 Pg. 309-315	Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Author(s): Summers Amy
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 72-79	Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint) Author(s): Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Sep/Oct 2021 Pg. 386-387	It's Time for a New Philosophy Author(s): Brunner Scott
Jul/Aug 2021 Pg. 288-295	Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 94-96	Low-dose Naltrexone Therapy for Psoriasis Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Mar/Apr 2020 Pg. 133	Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 305-311	Basics: Excipients Used in Nonsterile Compounding, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 325-339	Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy Author(s): Glaser Rebecca L, York Anne E
May/Jun 2019 Pg. 182-186	How to Develop and Maintain a Hazardous Drug List Author(s): Dillon L Rad
Mar/Apr 2019 Pg. 92	PreScription: Compounding with Cannabidiol Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 94-104	Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Author(s): Zur Eyal
Mar/Apr 2019 Pg. 106-111	Nimodipine Compounded Oral Suspension: A True Documented Medical Need Author(s): McElhiney Linda F
Jan/Feb 2019 Pg. 23-31	Topical Treatment of Primary Focal Hyperhidrosis, Part 1 Author(s): Zur Eyal
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 55	Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 444	PreScription: Standardized Concentrations: Pro or Con? Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 446-454	Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Author(s): Zur Eyal
Sep/Oct 2018 Pg. 358-366	Current Trends and Emerging Priorities in Compounded Preparations for Children Author(s): Parrish Richard H II
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 172-175	Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Author(s): Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Jan/Feb 2017 Pg. 6-16	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3 Author(s): Deleruyelle Laura J
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Nov/Dec 2016 Pg. 526-527	PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Author(s): Rost Erika
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
Sep/Oct 2016 Pg. 389-396	Basics of Compounding: Clinical Pharmaceutics, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
May/Jun 2016 Pg. 217-222	Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Author(s): Akers Michael J
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Nov/Dec 2015 Pg. 465-469	Root Cause Analysis, Part 1: Nonsterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Sep/Oct 2015 Pg. 357-365	Novel Approaches to Topical Psoriasis Therapy Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2015 Pg. 334-336	Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Author(s): Puertos Enrique, Spencer Melissa
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Sep/Oct 2014 Pg. 418-426	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
May/Jun 2014 Pg. 203-207	Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 24-27	Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Author(s): Wung Deanna
Jul/Aug 2012 Pg. 276-286	Compounding Prokinetic Medications for Companion Animals Author(s): Gaskins Jessica
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Jul/Aug 2011 Pg. 290-300	Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Mar/Apr 2011 Pg. 174-175	PostScription: Commentary: Discussion on the Safety of Topical Prilocaine Author(s): Bramwell Bethany L
Jan/Feb 2011 Pg. 32-40	Maillard Reactions in Pharmaceutical Formulations and Human Health Author(s): Newton David W
Jan/Feb 2011 Pg. 41	Toxicities Associated with Topical Anesthetics Author(s): Bramwell Bethany L
Jan/Feb 2011 Pg. 44-47	Marketing Vitamins, Minerals, and Other Nutrients Author(s): Kress Robert B
Jan/Feb 2011 Pg. 71	Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 374-380	Bioidentical Hormones in the News Author(s): Bramwell Bethany L
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
Mar/Apr 2010 Pg. 105-107	Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? Author(s): Williams LaVonn A
Mar/Apr 2010 Pg. 165-170	Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Author(s): Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Mar/Apr 2010 Pg. 171-173	Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders Author(s): Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
Jan/Feb 2010 Pg. 6-8	When Traditional Medicine Fails Author(s): Bash Robert
Jan/Feb 2010 Pg. 32-38	Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting Author(s): McElhiney Linda F
Jul/Aug 2009 Pg. 314-317	Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009 Pg. 270-275	The Physiologic Role and Use of Estriol Author(s): Paoletti Jim E
May/Jun 2009 Pg. 218-219	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 402-404	Equine Anesthesia: Triple Drip Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 426-430	Excipient Choices for Special Populations Author(s): Nagel-Edwards Karen M, Ko James Y
Jul/Aug 2008 Pg. 284	PreScription: First Estriol, Then What? Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 295-304	Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jan/Feb 2008 Pg. 4	PreScription: Year Number 12…And Still Much Work to Do Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 74-82	Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists Author(s): Huffman DC, Holmes Erin R
Sep/Oct 2007 Pg. 417	Acetylcysteine 200-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 418	Acetylcysteine 200-mg Packets Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 438-439	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 434-435	Ronidazole in the Treatment of Trichomonad Infections in Cats Author(s): Davidson Gigi S
Jul/Aug 2006 Pg. 288-290	Hospice Symptom Relief Kit: An Update Author(s): Petrin Ronald L
May/Jun 2006 Pg. 222	Granisetron 0.05-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 224	Mesna 20-mg/mL Syrup Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 89-93	Hospice from a Compounding Pharmacist's Perspective Author(s): Jones Marty
Mar/Apr 2006 Pg. 100-102	The Story of Hospice Author(s): Kuntz Rachael